101.
Recent Clinical Studies of the Effects of Lipid-Modifying Therapies
by Gotto, Antonio M., MD, DPhil
The American journal of cardiology, 2012, Vol.110 (1), p.15A-26A
102.
The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): Rationale, Design, and Methods
by Williamson, Jeff D., MD, MHS
The American journal of cardiology, 2007, Vol.99 (12), p.S112-S122
103.
Rationale and Design for the Blood Pressure Intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
by Cushman, William C., MD
The American journal of cardiology, 2007, Vol.99 (12), p.S44-S55
104.
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial
by Fang, James C
The Lancet (British edition), 2002, Vol.359 (9312), p.1108-1113
105.
Effect of glycemic and lipid achievements on clinical outcomes type 2 diabetic, Chinese patients with stable coronary artery disease
by Li, Sha
Journal of diabetes and its complications, 2016, Vol.30 (1), p.115-120
106.
Lipoprotein-Associated Phospholipase A2 : A Risk Marker or a Risk Factor?
by Lerman, Amir, MD
The American journal of cardiology, 2008, Vol.101 (12), p.S11-S22
107.
Predictors of High On-Aspirin Platelet Reactivity in High-Risk Vascular Patients Treated With Single or Dual Antiplatelet Therapy
by Amsallem, Myriam, MD
The American journal of cardiology, 2015, Vol.115 (9), p.1305-1310
108.
Inflammation in Diabetes Mellitus: Role of Peroxisome Proliferator-Activated Receptor–α and Peroxisome Proliferator-Activated Receptor–γ Agonists
by Libby, Peter, MD
The American journal of cardiology, 2007, Vol.99 (4), p.27-40
109.
Statins and myocardial infarction: Type, dose and administration time –does it matter?
by Papageorgiou, Nikolaos, MD PhD
Trends in cardiovascular medicine, 2016, Vol.26 (5), p.433-441
110.
Radiation-induced coronary artery disease: a second survivorship challenge?
by Gupta, Dipti
Future oncology (London, England), 2015-07-01, Vol.11 (14), p.2017-2020
111.
Secondary prevention in patients with vascular disease. A population based study on the underuse of recommended medications
by Béjot, Yannick
Journal of neurology, neurosurgery and psychiatry, 2013-03, Vol.84 (3), p.348-353
112.
Insulin resistance, inflammation, and the prediabetic state
by Haffner, Steven M
The American journal of cardiology, 2003, Vol.92 (4), p.18-26
113.
A retrospective cross-sectional study on the association between tobacco smoking and incidence of ST-segment elevation myocardial infarction and cardiovascular risk factors
by Steele, Lloyd
Postgraduate medical journal, 2015-09, Vol.91 (1079), p.492-496
114.
A comparison of postoperative effects of bariatric surgery on medical markers of morbidity
by Bonner, Gwen L., M.D
The American journal of surgery, 2014, Vol.208 (6), p.897-902
115.
Tissue Omega-6/Omega-3 Fatty Acid Ratio and Risk for Coronary Artery Disease
by Harris, William S
The American journal of cardiology, 2006, Vol.98 (4), p.19-26
116.
High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from framingham to the veterans affairs high-density lipoprotein in...
by Boden, William E
The American journal of cardiology, 2000, Vol.86 (12), p.19-22
117.
Radiation-related heart and vascular disease
by Yusuf, Syed Wamique
Future oncology (London, England), 2015-07-01, Vol.11 (14), p.2067-2076
118.
Anti-atherogenic effects of seabuckthorn ( Hippophaea rhamnoides) seed oil
by Basu, M
Phytomedicine (Stuttgart), 2007, Vol.14 (11), p.770-777
119.
Effect of Rosuvastatin on Coronary Flow Reserve in Patients With Systemic Hypertension
by Sun, Byung Joo, MD
The American journal of cardiology, 2014, Vol.114 (8), p.1234-1237
120.
Prevention of exercise-related injuries and adverse events in patients with type 2 diabetes
by Mendes, Romeu
Postgraduate Medical Journal, 2013-12, Vol.89 (1058), p.715-721
